featured
Efficacy and Safety of Pegylated Interferon Lambda for Early Treatment of COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Treatment with Pegylated Interferon Lambda for Covid-19
N. Engl. J. Med 2023 Feb 09;388(6)518-528, G Reis, EAS Moreira Silva, DC Medeiros Silva, L Thabane, VHS Campos, TS Ferreira, CVQ Santos, AMR Nogueira, APFG Almeida, LCM Savassi, AD Figueiredo-Neto, ACF Dias, AM Freire Júnior, C Bitarães, AC Milagres, ED Callegari, MIC Simplicio, LB Ribeiro, R Oliveira, O Harari, LA Wilson, JI Forrest, H Ruton, S Sprague, P McKay, CM Guo, EH Limbrick-Oldfield, S Kanters, GH Guyatt, CR Rayner, C Kandel, MJ Biondi, R Kozak, B Hansen, MA Zahoor, P Arora, C Hislop, I Choong, JJ Feld, EJ Mills, JS GlennFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.